Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Amylyx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amylyx Pharmaceuticals Inc
Rating: 2.00525
Author: Trendlyne DVM scores

about

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

15.01 -0.75 (-4.76%)

New 52W High in past week

1.5M

XNAS Volume

XNAS 26 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.0 / 100

Technically Bullish

74.2 / 100

1Yr Price target upside is 35%

9 analysts

Amylyx Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

New 52W High in past week

SWOT Analysis

Amylyx Pharma Inc Live Price Chart